Indigenous Dna Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Revenue 54.64%
(FY 2019)
- Profit 194.43%
(FY 2019)
- Ebitda -506.88%
(FY 2019)
- Net Worth 189.12%
(FY 2019)
- Total Assets 862.31%
(FY 2019)
About Indigenous Dna
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prescila Benjamin, Kino Clement, and Syed Syedkhader serve as directors at the Company.
- CIN/LLPIN
U73200TN2017PTC117324
- Company No.
117324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2017
- Date of AGM
28 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Indigenous Dna Private Limited offer?
Indigenous Dna Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit.
Who are the key members and board of directors at Indigenous Dna?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prescila Benjamin  | Director | 29-Jun-2017 | Current |
| Kino Clement | Director | 15-Oct-2017 | Current |
| Syed Syedkhader | Director | 15-Oct-2017 | Current |
Financial Performance of Indigenous Dna.
Indigenous Dna Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 54.64% increase. The company also saw a substantial improvement in profitability, with a 194.43% increase in profit. The company's net worth Soared by an impressive increase of 189.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indigenous Dna?
Unlock access to Indigenous Dna's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indigenous Dna?
Unlock and access historical data on people associated with Indigenous Dna, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indigenous Dna, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indigenous Dna's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
